Dr. Joshua Brody is the Director of the Lymphoma Immunotherapy Program at Icahn School of Medicine at Mount Sinai. the Brody Lab studies basic and applied tumor immunology for the development of cancer immunotherapies, particularly for lymphomas and melanomas. They aim to improve cancer vaccines by priming anti-tumor responses at the tumor site of each patient (in situ vaccine).

Listen to the episode here.